Medical Xpress September 4, 2024
Researchers at the University of Kentucky are testing the effectiveness of a vaccine that may be able to treat pancreatic cancer.
As one of 15 research institutions across the nation taking part in the new clinical trial, UK HealthCare will test a vaccine, made with the same sequencing technology as the COVID vaccine, to try to lessen the recurrence of pancreatic cancer.
“Patients with pancreatic cancer need additional treatment options. Pancreatic cancer is one of the cancers that we have made little, if any, progress over the last couple of decades, and so this is a potential major breakthrough,” said Dr. Joseph Kim, chief of surgical oncology at UK’s Markey Cancer Center.
To be eligible for the trial, patients have...
Today's Sponsors
Today's Sponsor